返回
C
Cancer Research Uk
学者数7.1K
论文数4.1K
被引数22
关联论文 (2707)
发表时间
Responses can be achieved with a combination of the MEK inhibitor selumetinib and dexamethasone in patients with relapsed/refractory RAS-pathway mutated acute lymphoblastic leukemia: Results of a parallel cohort, dose-finding and expansion phase I/II trial联合使用MEK抑制剂塞鲁美替尼和地塞米松可在RAS通路突变的复发/难治性急性淋巴细胞白血病患者中实现应答:一项平行队列、剂量探索和扩展的I/II期试验结果

